406 related articles for article (PubMed ID: 29391266)
1. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
2. Association Between Proton Pump Inhibitor Use and Cognitive Function in Women.
Lochhead P; Hagan K; Joshi AD; Khalili H; Nguyen LH; Grodstein F; Chan AT
Gastroenterology; 2017 Oct; 153(4):971-979.e4. PubMed ID: 28728964
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between proton pump inhibitor use and decline in cognitive performance in the ELSA-Brasil cohort.
Dos Santos AS; de Menezes ST; Bensenor IM; Goulart AC; Barreto SM; Figueiredo RC
Eur J Clin Pharmacol; 2021 Nov; 77(11):1725-1735. PubMed ID: 34014336
[TBL] [Abstract][Full Text] [Related]
4. Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period.
Haastrup PF; Paulsen MS; Christensen RD; Søndergaard J; Hansen JM; Jarbøl DE
Aliment Pharmacol Ther; 2016 Jul; 44(1):78-87. PubMed ID: 27137875
[TBL] [Abstract][Full Text] [Related]
5. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia.
Goldstein FC; Steenland K; Zhao L; Wharton W; Levey AI; Hajjar I
J Am Geriatr Soc; 2017 Sep; 65(9):1969-1974. PubMed ID: 28590010
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
8. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
10. Cognitive problems of breast cancer survivors on proton pump inhibitors.
Madison AA; Woody A; Bailey B; Lustberg MB; Ramaswamy B; Wesolowski R; Williams N; Reinbolt R; VanDeusen JB; Sardesai S; Malarkey WB; Kiecolt-Glaser JK
J Cancer Surviv; 2020 Apr; 14(2):226-234. PubMed ID: 31933149
[TBL] [Abstract][Full Text] [Related]
11. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
12. Chronic omeprazole use in the elderly is associated with decreased risk of dementia and cognitive decline.
Weiss A; Gingold-Belfer R; Boltin D; Beloosesky Y; Koren-Morag N; Meyerovitch J; Sharon E; Schmilovitz-Weiss H
Dig Liver Dis; 2022 May; 54(5):622-628. PubMed ID: 34949554
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
15. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
16. Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study.
Lødrup A; Pottegård A; Hallas J; Bytzer P
Gut; 2014 Oct; 63(10):1544-9. PubMed ID: 24474384
[TBL] [Abstract][Full Text] [Related]
17. Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study.
Hwang IC; Chang J; Park SM
PLoS One; 2018; 13(9):e0203918. PubMed ID: 30208110
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
Liu Y; Zhu X; Li R; Zhang J; Zhang F
BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
[TBL] [Abstract][Full Text] [Related]
19. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
20. Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review.
Batchelor R; Gilmartin JF; Kemp W; Hopper I; Liew D
J Gastroenterol Hepatol; 2017 Aug; 32(8):1426-1435. PubMed ID: 28128476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
